Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 29, Issue 10, Pages 781-792
Publisher
Informa UK Limited
Online
2019-10-10
DOI
10.1080/13543776.2019.1679117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 – 2018)
- (2019) Andrea Angeli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits
- (2018) Nagwa Hussein Fouda et al. DRUG DELIVERY
- Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
- (2018) Maryam Kouchak et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Discovery of β-Adrenergic Receptors Blocker–Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy
- (2018) Alessio Nocentini et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation
- (2018) Jingfen Sun et al. Drug Design Development and Therapy
- Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP–Glaucoma
- (2018) Ian Pitha et al. Translational Vision Science & Technology
- Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
- (2017) Nadia Morsi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles
- (2017) Chun Gwon Park et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
- (2017) André Vicente et al. OPHTHALMIC RESEARCH
- Monothiocarbamates Strongly Inhibit Carbonic Anhydrases in Vitro and Possess Intraocular Pressure Lowering Activity in an Animal Model of Glaucoma
- (2016) Daniela Vullo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
- (2016) Jie Fu et al. MOLECULAR PHARMACEUTICS
- Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents
- (2015) Marco Bragagni et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
- (2015) Murat Bozdag et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors To Lower Intraocular Pressure
- (2015) Qinhua Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Poly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action
- (2015) Fabrizio Carta et al. JOURNAL OF MEDICINAL CHEMISTRY
- Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents
- (2014) Konstantin Chegaev et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma:vitroandvivostudy
- (2014) Fengzhen Wang et al. JOURNAL OF DRUG TARGETING
- Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity, and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups
- (2014) Murat Bozdag et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops
- (2014) Tina T. Wong et al. Drug Delivery and Translational Research
- Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes
- (2013) María J. Mora et al. CARBOHYDRATE POLYMERS
- Development,in vitroandin vivocharacterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide
- (2013) Parmanand Verma et al. DRUG DELIVERY
- Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulatein situgel for sustained ocular delivery:in vitro. ex vivoevaluation and pharmacodynamic study
- (2013) Jyotsana Singh et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Antiglaucoma carbonic anhydrase inhibitors: a patent review
- (2013) Emanuela Masini et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Liposomes and nanotechnology in drug development: focus on ocular targets
- (2013) Miki Honda et al. International Journal of Nanomedicine
- Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits
- (2013) Vijay Mishra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Xanthates and Trithiocarbonates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Effects in Vivo
- (2013) Fabrizio Carta et al. JOURNAL OF MEDICINAL CHEMISTRY
- A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma
- (2012) Daniel D. Long et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
- (2012) Vincenzo Alterio et al. CHEMICAL REVIEWS
- Penetration enhancer-containing vesicles: Composition dependence of structural features and skin penetration ability
- (2012) M. Manconi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo
- (2012) Fabrizio Carta et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
- (2012) Kang Zhang et al. NATURE REVIEWS DRUG DISCOVERY
- Novel therapies for glaucoma: a patent review 2007 – 2011
- (2011) Fabrizio Carta et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Glaucoma
- (2011) Harry A Quigley LANCET
- Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions
- (2009) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started